The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kardos P, Hagedorn-Peinz I
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017-12-01
Col·lecció:International Journal of COPD
Matèries:
COPD
dual-bronchodilators
FEV1
indacaterol/glycopyrronium
treatment preference
treatment satisfaction
Accés en línia:https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars